Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

BI chief “regrets” Brexit, but continues to invest in UK
Pharmaforum
Thu, 04/18/19 - 11:05 am
Tags:
UK, Brexit, Boehringer Ingelheim
PureTech, Boehringer partner to develop lymph node-targeting cancer immunotherapies
BioCentury
Thu, 04/18/19 - 09:50 am
Tags:
Boehringer Ingelheim, PureTech, lymphatic targeting, GI cancers
Boehringer’s blockbuster Spiriva under pressure, profits down
Pharmaforum
Wed, 04/17/19 - 09:50 am
Tags:
Boehringer Ingelheim, earnings, Spiriva
Boehringer Ingelheim buys MacroDel platform developer ICD Therapeutics
Pharmaceutical Business Review
Mon, 04/1/19 - 12:19 pm
Tags:
Boehringer Ingelheim, MacroDel biologics, M&A, ICD Therapeutics
Hand over your Humira biosim launch plans; judge tells Boehringer in AbbVie patent fight
Fierce Pharma
Wed, 02/27/19 - 12:06 pm
Tags:
AbbVie, Boehringer Ingelheim, Humira, biosimilars
Boehringer Ingelheim and 3BP Forge a Multi-Year Collaboration
BioSpace
Fri, 02/22/19 - 11:48 am
Tags:
Boehringer Ingelheim, 3B Pharmaceuticals, drug discovery, peptides
Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
Pharmaceutical Business Review
Fri, 02/15/19 - 10:13 am
Tags:
Boehringer Ingelheim, Eli Lilly, glimepiride, linagliptin, Tradjenta, type 2 diabetes, clinical trials
Boehringer Ingelheim and IBM link up for blockchain-powered clinical trials in Canada
Fierce Biotech
Tue, 02/12/19 - 12:03 pm
Tags:
Boehringer Ingelheim, IBM, Canada, blockchain, clinical trials
AbbVie loses bid to hoard documents in Humira patent fight with Boehringer
Fierce Pharma
Mon, 02/11/19 - 12:21 pm
Tags:
Boehringer Ingelheim, AbbVie, biosimilars, Humira, patents
Boehringer taps BioMed X to source psychiatric disease research proposals
BioCentury
Sat, 01/19/19 - 06:20 pm
Tags:
Boehringer Ingelheim, BioMed, drug discovery, psychiatric disease
Boehringer building out biologics manufacturing in China
BioPharma Dive
Thu, 01/17/19 - 11:59 pm
Tags:
China, drug manufacturing, Boehringer Ingelheim, biologics
Bioharmony, Boehringer partner to develop antimicrobials
BioCentury
Tue, 01/15/19 - 11:57 pm
Tags:
Boehringer Ingelheim, Bioharmony Therapeutics, antimicrobials
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
Tags:
clinical trials, Takeda, Zinfandel Pharmaceuticals, pioglitazone, Alzheimer's disease, Boehringer Ingelheim, BI 409306, Merck, verubecestat, Celgene, MS, ozanimod, Incyte, ID01, melanoma, vTv Therapeutics, azeliragon, Roche, Tecentriq, Exelixis, colorectal cancer, JNJ, atabacestat, Sareptat Therapeutics, DMD, Exondys 51, Alkermes, ALKS-5461, clinical depression
Boehringer offloads an mTOR cancer drug as Xynomic plots a quick advance in the clinic
Endpoints
Fri, 12/21/18 - 10:15 am
Tags:
Boehringer Ingelheim, R&D, Xynomic, mTOR
Boehringer employees go door-to-door delivering holiday hope to lung cancer patients
Fierce Pharma
Mon, 12/17/18 - 09:04 am
Tags:
Boehringer Ingelheim, patients, lung cancer
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Fierce Pharma
Thu, 12/13/18 - 12:24 pm
Tags:
Sanofi, Lantus, Eli Lilly, Boehringer Ingelheim, Mylan Labs, generics, diabetes, insulin, basal insulin
Boehringer Ingelheim plans to cut about 300 jobs in France
Yahoo/Reuters
Mon, 12/10/18 - 11:47 pm
Tags:
France, Boehringer Ingelheim, layoffs
Boehringer dropping ex-U.S. biosimilars programs
BioCentury
Wed, 11/28/18 - 11:49 pm
Tags:
Boehringer Ingelheim, biosimilars
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
Tags:
cancer, breast cancer, lung cancer, drug approvals, AstraZeneca, Takeda, Ariad Pharmaceuticals, Merck, Pfizer, Novartis, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Puma Biotechnology, Mylan, Genentech
Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million Upfront and $280 Million in Biobucks
BioSpace
Thu, 11/15/18 - 10:46 am
Tags:
cancer, R&D, drug development, Boehringer Ingelheim, Epizyme

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.